Menglei Zhu, Ph.D. - Publications
Affiliations: | 2010 | University of Kentucky, Lexington, KY |
Area:
ToxicologyYear | Citation | Score | |||
---|---|---|---|---|---|
2010 | Zhu ML, Horbinski CM, Garzotto M, Qian DZ, Beer TM, Kyprianou N. Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer. Cancer Research. 70: 7992-8002. PMID 20807808 DOI: 10.1158/0008-5472.Can-10-0585 | 0.509 | |||
2010 | Zhu ML, Kyprianou N. Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 769-77. PMID 19901020 DOI: 10.1096/Fj.09-136994 | 0.549 | |||
2008 | Zhu ML, Kyprianou N. Androgen receptor and growth factor signaling cross-talk in prostate cancer cells. Endocrine-Related Cancer. 15: 841-9. PMID 18667687 DOI: 10.1677/Erc-08-0084 | 0.533 | |||
2008 | Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. The Prostate. 68: 287-95. PMID 18163430 DOI: 10.1002/Pros.20698 | 0.522 | |||
Show low-probability matches. |